Related references
Note: Only part of the references are listed.Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ribavirin Exerts Differential Effects on Functions of Cd4+ Th1, Th2, and Regulatory T Cell Clones in Hepatitis C
Bettina Langhans et al.
PLOS ONE (2012)
SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets
Mario Roederer et al.
CYTOMETRY PART A (2011)
Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
Mario Skarica et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome
Sarah Gheuens et al.
JOURNAL OF VIROLOGY (2011)
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
Ludwig Kappos et al.
LANCET NEUROLOGY (2011)
The Changing Landscape of Progressive Multifocal Leukoencephalopathy
Sachin Kedar et al.
Current Infectious Disease Reports (2011)
JC Virus Persistence Following Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated with Natalizumab
Caroline F. Ryschkewitsch et al.
ANNALS OF NEUROLOGY (2010)
Anti-JC Virus Antibodies: Implications for PML Risk Stratification
Leonid Gorelik et al.
ANNALS OF NEUROLOGY (2010)
Interleukin-15 and Interleukin-12 Are Elevated in Serum and Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis
Michael Rentzos et al.
EUROPEAN NEUROLOGY (2010)
IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform
Patricia A. Darrah et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Discrepant findings in immune responses to JC virus in patients receiving natalizumab
Chen S. Tan et al.
LANCET NEUROLOGY (2010)
Discrepant findings in immune responses to JC virus in patients receiving natalizumab Reply
Samantha Jilek et al.
LANCET NEUROLOGY (2010)
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study
Samantha Jilek et al.
LANCET NEUROLOGY (2010)
IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection
David G. Brooks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers
M. Khademi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Cutting Edge: Natalizumab Blocks Adhesion but Not initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis
Caroline Coisne et al.
JOURNAL OF IMMUNOLOGY (2009)
JC Virus-Specific Immune Responses in Human Immunodeficiency Virus Type 1 Patients with Progressive Multifocal Leukoencephalopathy
Nina Khanna et al.
JOURNAL OF VIROLOGY (2009)
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells
P. Kivisakk et al.
NEUROLOGY (2009)
Reemergence of PML in Natalizumab-Treated Patients - New Cases, Same Concerns
Eugene O. Major
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
Yiping Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immune responses against persistent viral infections: Possible avenues for immunotherapeutic interventions
Shinichiro Fuse et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Levels of IL-15 in serum and cerebrospinal fluid of patients with Behcet's disease
K. Hamzaoui et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Interleukin-10 determines viral clearance or persistence in vivo
David G. Brooks et al.
NATURE MEDICINE (2006)
IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia
M. Rentzos et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2006)
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve et al.
ANNALS OF NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis
M Rentzos et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy
RA Du Pasquier et al.
BRAIN (2004)
Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy
J Gasnault et al.
AIDS (2003)
Association of prolonged survival in HLA-A2(+) progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope
IJ Koralnik et al.
JOURNAL OF IMMUNOLOGY (2002)
JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy
IJ Koralnik et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
